- Home
- CCEC vs NKTR Comparison
CCEC vs NKTR Comparison
Compare CCEC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEC
- NKTR
- Stock Information
- Founded
- CCEC 2007
- NKTR 1990
- Country
- CCEC Greece
- NKTR United States
- Employees
- CCEC N/A
- NKTR N/A
- Industry
- CCEC Marine Transportation
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- CCEC Consumer Discretionary
- NKTR Health Care
- Exchange
- CCEC Nasdaq
- NKTR Nasdaq
- Market Cap
- CCEC 1.2B
- NKTR 1.1B
- IPO Year
- CCEC 2007
- NKTR 1994
- Fundamental
- Price
- CCEC $20.90
- NKTR $57.07
- Analyst Decision
- CCEC Buy
- NKTR Strong Buy
- Analyst Count
- CCEC 2
- NKTR 5
- Target Price
- CCEC $26.00
- NKTR $89.00
- AVG Volume (30 Days)
- CCEC 7.2K
- NKTR 799.2K
- Earning Date
- CCEC 10-30-2025
- NKTR 11-06-2025
- Dividend Yield
- CCEC 2.91%
- NKTR N/A
- EPS Growth
- CCEC 304.13
- NKTR N/A
- EPS
- CCEC 4.79
- NKTR N/A
- Revenue
- CCEC $421,795,000.00
- NKTR $62,600,000.00
- Revenue This Year
- CCEC $16.66
- NKTR N/A
- Revenue Next Year
- CCEC $14.48
- NKTR N/A
- P/E Ratio
- CCEC $4.30
- NKTR N/A
- Revenue Growth
- CCEC 28.41
- NKTR N/A
- 52 Week Low
- CCEC $14.09
- NKTR $6.48
- 52 Week High
- CCEC $24.83
- NKTR $66.92
- Technical
- Relative Strength Index (RSI)
- CCEC 48.60
- NKTR 49.56
- Support Level
- CCEC $19.60
- NKTR $54.59
- Resistance Level
- CCEC $21.12
- NKTR $59.38
- Average True Range (ATR)
- CCEC 0.86
- NKTR 3.78
- MACD
- CCEC -0.04
- NKTR -0.76
- Stochastic Oscillator
- CCEC 58.46
- NKTR 31.45
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.